Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:S40–S7.
Article
Google Scholar
Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655–65.
Article
CAS
PubMed
Google Scholar
Awad KS, West JD, de Jesus PV, MacLean M. Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference series). Pulm Circ. 2016;6:285–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41.
Article
PubMed
Google Scholar
Fairweather D, Petri MA, Coronado MJ, Cooper LT Jr. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol. 2012;8:269–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fairweather D, Cooper LT, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38:7–46.
Arnold AP, Cassis LA, Eghbali M, Reue K, Sandberg K. Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases. Arterioscler Thromb Vasc Biol. 2017;37:746–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lahm T, Tuder RM, Petrache I. Progress in solving the sex hormone paradox in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014;307:L7–L26.
Article
CAS
PubMed
Google Scholar
Mair KM, Johansen AKZ, Wright AF, Wallace E, MacLean MR. Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol. 2014;171:567–79.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wei Y-C, George NI, Chang C-W, Hicks KA, Cheung A, Cushman W. Assessing sex differences in the risk of cardiovascular disease and mortality per increment in systolic blood pressure: a systematic review and meta-analysis of follow-up studies in the United States. PLoS One. 2017;12:e0170218.
Article
PubMed
PubMed Central
CAS
Google Scholar
Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216–23.
Article
CAS
PubMed
Google Scholar
Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007;30:1103–10.
Article
CAS
PubMed
Google Scholar
Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104–9.
Article
CAS
PubMed
Google Scholar
Jing Z-C, Xu X-Q, Han Z-Y, Wu Y, Deng K-W, Wang H, et al. Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132:373–9.
Article
PubMed
Google Scholar
Jansa P, Jarkovsky J, Al-Hiti H, Popelova J, Ambroz D, Zatocil T, et al. Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC Pulm Med. 2014;14:45.
Article
PubMed
PubMed Central
Google Scholar
Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:790–6.
Article
PubMed
Google Scholar
Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France. Am J Respir Crit Care Med. 2006;173:1023–30.
Article
PubMed
Google Scholar
McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21:8–18.
Article
CAS
PubMed
Google Scholar
Escribano-Subias P, Blanco I, Lopez-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J. 2012;40:596–603.
Article
PubMed
Google Scholar
Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, et al. Anticoagulation and survival in pulmonary arterial hypertension. Circulation. 2014;129:57–65.
Article
CAS
PubMed
Google Scholar
Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension. Chest. 2010;137:376–87.
Article
PubMed
Google Scholar
Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, et al. Portopulmonary hypertension: a report from the US-based REVEAL registry. Chest. 2012;141:906–15.
Article
PubMed
Google Scholar
Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173:600–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11:754–65.
Article
PubMed
Google Scholar
Montani D, Günther S, Dorfmüller P, Perros F, Girerd B, Garcia G, et al. Pulmonary arterial hypertension. Orphanet J Rare Dis. 2013;8:97.
Article
PubMed
PubMed Central
Google Scholar
Mair KM, Wright AF, Duggan N, Rowlands DJ, Hussey MJ, Roberts S, et al. Sex-dependent influence of endogenous estrogen in pulmonary hypertension. Am J Respir Crit Care Med. 2014;190:456–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li JH, Safford RE, Aduen JF, Heckman MG, Crook JE, Burger CD. Pulmonary hypertension and thyroid disease. Chest. 2007;132:793–7.
Article
PubMed
Google Scholar
Gisel JJ, Daniels JT, Burger CD. Clinical utility of thyroperoxidase antibody testing in patients with pulmonary hypertension. Thyroid Sci. 2009;4:CLS1–5.
Borazan N, Furst D. Systemic sclerosis, scleroderma. In: Rose N, Mackay I, editors. The autoimmune diseases. 5th ed. London: Elsevier; 2014. p. 463–80.
Chapter
Google Scholar
Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E. Pulmonary arterial hypertension in patients with primary Sjögren’s syndrome. Autoimmune Dis. 2014;2014:710401.
Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, et al. The prognosis of pulmonary arterial hypertension associated with primary Sjögren’s syndrome: a cohort study. Lupus. 2018;1:961203318756287. [Epub ahead of print].
Roberts-Thomson PJ, et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J. 2001;31:220–9.
Article
CAS
PubMed
Google Scholar
Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008;58:15–25.
Article
PubMed
Google Scholar
Hussein H, Lee P, Chau C, Johnson SR. The effect of male sex on survival in systemic sclerosis. J Rheumatol. 2014;41:2193–200.
Article
PubMed
Google Scholar
Schuna A. Autoimmune rheumatic diseases in women. J Am Pharm Assoc. 2002;42:612–23.
Google Scholar
Hln C, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37:223–35.
Article
Google Scholar
Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016;75:163–9.
Article
PubMed
Google Scholar
Pasarikovski CR, Granton JT, Roos AM, Sadeghi S, Kron AT, Thenganatt J, et al. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study. Arthritis Res Ther. 2016;18:30.
Article
PubMed
PubMed Central
CAS
Google Scholar
Fairweather D. Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol. 2014;8:49–59.
PubMed
Google Scholar
Fairweather D. Autoimmune skin diseases: role of sex hormones, vitamin D, and menopause. In: Farage M, Miller K, Woods N, Maibach H, editors. Skin, mucosa and menopause. Berlin Heidelberg: Springer; 2015. p. 359–81.
Google Scholar
Collins N, Bastian B, Quiqueree L, Jones C, Morgan R, Reeves G. Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: pulmonary hypertension assessment and screening evaluation using stress echocardiography (PHASE-I). Eur J Echocardiogr. 2006;7:439–46.
Article
PubMed
Google Scholar
Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144:1346–56.
Article
PubMed
PubMed Central
Google Scholar
Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F. Genetic factors and systemic sclerosis. Autoimmun Rev. 2016;15:427–32.
Article
CAS
PubMed
Google Scholar
Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012;141:363–73.
Article
PubMed
Google Scholar
Barsotti S, Stagnaro C, d'Ascanio A, Della RA. One year in review 2016: systemic sclerosis. Clin Exp Rheumatol. 2004;34(Suppl 100):3–13.
Google Scholar
Coghlan G. Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Eur Respir J. 2013;42:888–90.
Article
PubMed
Google Scholar
Dinser R, Frerix M, Meier FMP, Klingel K, Rolf A. Endocardial and myocardial involvement in systemic sclerosis—is there a relevant inflammatory component? Joint Bone Spine. 2013;80:320–3.
Article
CAS
PubMed
Google Scholar
Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum. 2014;43:526–35.
Article
PubMed
Google Scholar
Ali H, Ng KR, Low AHL. A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis. Int J Rheum Dis. 2015;18:276–86.
Article
PubMed
Google Scholar
Bissell L-A, Md Yusof MY, Buch MH. Primary myocardial disease in scleroderma—a comprehensive review of the literature to inform the UK systemic sclerosis study group cardiac working group. Rheumatology (Oxford). 2017;56:882–95.
Article
Google Scholar
Ozen G, Inanc N, Unal AU, Korkmaz F, Sunbul M, Ozmen M, et al. Subclinical atherosclerosis in systemic sclerosis: not less frequent than rheumatoid arthritis and not detected with cardiovascular risk indices. Arthritis Care Res. 2016;68:1538–46.
Article
Google Scholar
Thakkar V, Lau EM. Connective tissue disease-related pulmonary arterial hypertension. Best Pract Res Clin Rheumatol. 2016;30:22–38.
Article
PubMed
Google Scholar
Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med (Lond). 2015;15:s58–63.
Article
Google Scholar
Díaz-López C, Geli C, Corominas H, Malat N, Diaz-Torner C, Llobet JM, et al. Are there clinical or serological differences between male and female patients with primary Sjögren’s syndrome? J Rheumatol. 2004;31:1352–5.
PubMed
Google Scholar
Ramos-Casals M, Solans R, Rosas J, Camps M, Gil A, Del Pino-Montes JJ-A, et al. Primary Sjögren’s syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008;87:210–9.
Article
CAS
PubMed
Google Scholar
Horvath IF, Szanto A, Papp G, Zeher M. Clinical course, prognosis, and cause of death in primary Sjögren’s syndrome. J Immunol Res. 2014;2014:1–8.
Kronbichler A, Mayer G, Alfredsson L, Zhang H, Gonzalez AG, Richardson M, et al. Renal involvement in autoimmune connective tissue diseases. BMC Med. 2013;11:95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prete M, Fatone MC, Favoino E, Perosa F. Raynaud's phenomenon: from molecular pathogenesis to therapy. Autoimmun Rev. 2014;13:655–67.
Article
CAS
PubMed
Google Scholar
Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol. 2011;6:509–37.
Article
CAS
PubMed
Google Scholar
Guiducci S, Giacomelli R, Cerinic MM. Vascular complications of scleroderma. Autoimmun Rev. 2007;6:520–3.
Article
PubMed
Google Scholar
Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol. 2012;8:469–79.
Article
CAS
PubMed
Google Scholar
Brandt JE, Priori R, Valesini G, Fairweather D. Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19.
Article
PubMed
PubMed Central
CAS
Google Scholar
Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902–12.
Article
PubMed
Google Scholar
Saito T, Miyagawa K, Chen SY, Tamosiuniene R, Wang L, Sharpe O, et al. Upregulation of human endogenous retrovirus-K is linked to immunity and inflammation in pulmonary arterial hypertension. Circulation. 2017;136:1920–35.
Article
CAS
PubMed
Google Scholar
Pullamsetti SS, Savai R, Janssen W, Dahal BK, Seeger W, Grimminger F, et al. Inflammation, immunological reaction and role of infection in pulmonary hypertension. Clin Microbiol Infect. 2011;17:7–14.
Article
CAS
PubMed
Google Scholar
Newkirk MM. Rheumatoid factors: host resistance or autoimmunity? Clin Immunol. 2002;104:1–13.
Article
CAS
PubMed
Google Scholar
Dörner T, Egerer K, Feist E, Burmester GR. Rheumatoid factor revisited. Curr Opin Rheumatol. 2004;16:246–53.
Article
PubMed
Google Scholar
Carson DA, Chen PP, Kipps TJ, Radoux V, Jirik FR, Goldfien RD, et al. Idiotypic and genetic studies of human rheumatoid factors. Arthritis Rheum. 1987;30:1321–5.
Article
CAS
PubMed
Google Scholar
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
Article
CAS
PubMed
Google Scholar
Lapa AT, Appenzeller S, Bértolo MB. Schistosoma mansoni infection: an immune complex disease presenting with polyarthritis. Rheumatol Int. 2013;33:1341–3.
Article
CAS
PubMed
Google Scholar
Tamby MC, Chanseaud Y, Humbert M, Fermanian J, Guilpain P, Garcia-de-la-Peña-Lefebvre P, et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax. 2005;60:765–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tamby M, Humbert M, Guilain P, Servettaz A, Dupin N, Christner J, et al. Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Resp J. 2006;28:799–807.
Article
CAS
Google Scholar
Humbert M, Lau EMT, Montani D, Jais X, Sitbon O, Simonneau G. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation. 2014;130:2189–208.
Article
PubMed
Google Scholar
Pagán RJ, Lee AS, Austin CO, Burger CD. Screening for connective tissue disease in pulmonary arterial hypertension. South Med J. 2014;107:666–9.
Article
PubMed
CAS
Google Scholar
Dube SR, Fairweather D, Pearson WS, Felitti VJ, Anda RF, Croft JB. Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med. 2009;71:243–50.
Article
PubMed
PubMed Central
Google Scholar
Frustaci A, Petrosillo N, Vizza D, Francone M, Badagliacca R, Verardo R, et al. Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension. AIDS. 2014;28:2541–9.
Article
CAS
PubMed
Google Scholar
Ntusi NAB. HIV and myocarditis. Curr Opin HIV AIDS. 2017;12:561–5.
Article
PubMed
Google Scholar
Luetkens JA, Doerner J, Schwarze-Zander C, Wasmuth J-C, Boesecke C, Sprinkart AM, et al. Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients. Circ Cardiovasc Imaging. 2016;9:e004091.
Article
PubMed
Google Scholar
Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Rai ABS, Matthews PM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis—a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson. 2014;16:21.
Article
PubMed
PubMed Central
Google Scholar
West SG, Killian PJ, Lawless OJ. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis Rheum. 1981;24:662–8.
Article
CAS
PubMed
Google Scholar
Carette S, Turcotte J, Mathon G. Severe myositis and myocarditis in progressive systemic sclerosis. J Rheumatol. 1985;12:997–9.
CAS
PubMed
Google Scholar
Clemson BS, Miller WR, Luck JC, Feriss JA. Acute myocarditis in fulminant systemic sclerosis. Chest. 1992;101:872–4.
Article
CAS
PubMed
Google Scholar
Kerr LD, Spiera H. Myocarditis as a complication in scleroderma patients with myositis. Clin Cardiol. 1993;16:895–9.
Article
CAS
PubMed
Google Scholar
Liangos O, Neure L, Kühl U, Pauschinger M, Sieper J, Distler A, et al. The possible role of myocardial biopsy in systemic sclerosis. Rheumatology (Oxford). 2000;39:674–9.
Article
CAS
Google Scholar
Stack J, McLaughlin P, Sinnot C, Henry M, MacEneaney P, Eltahir A, et al. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Scand J Rheumatol. 2010;39:349–50.
Article
CAS
PubMed
Google Scholar
Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol. 1999;17:718–20.
CAS
PubMed
Google Scholar
Ohtsuka T, Yamazaki S. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol. 2004;150:1091–5.
Article
CAS
PubMed
Google Scholar
Lima JP. Study of the so-called "ectopical lesions" in Manson's schistosomiasis. II. Myocardial schistosomiasis. Rev Inst Med Trop Sao Paulo. 1969;11:290–3.
CAS
PubMed
Google Scholar
Chisty MM, Nargis M, Sato H, Inaba T, Kamiya H. Occurrence of myocarditis in rodents infected with Schistosoma mansoni. Southeast Asian J Trop Med Public Health. 1999;30:556–61.
CAS
PubMed
Google Scholar
Epelboin L, Jauréguiberry S, Estève J-B, Danis M, Komajda M, Bricaire F, et al. Myocarditis during acute schistosomiasis in two travelers. Am J Trop Med Hyg. 2010;82:365–7.
Article
PubMed
PubMed Central
Google Scholar
Nunes MCP, Guimarães Júnior MH, Diamantino AC, Gelape CL, Ferrari TCA. Cardiac manifestations of parasitic diseases. Heart. 2017;103:651–8.
Article
PubMed
Google Scholar
Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, et al. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol. 2006;176:3516–24.
Article
CAS
PubMed
Google Scholar
Imazio M, Cooper LT. Management of myopericarditis. Expert Rev Cardiovasc Ther. 2013;11:193–201.
Article
CAS
PubMed
Google Scholar
Bigna JJ, Sime PS, Koulla-Shiro S. HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment. AIDS Res Ther. 2015;12:36.
Article
PubMed
PubMed Central
Google Scholar
Martin YN, Pabelick CM. Sex differences in the pulmonary circulation: implications for pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2014;306:H1253–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hassoun PM, Mouthon L, Barber JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol. 2009;54:S10–S9.
Article
CAS
PubMed
Google Scholar
Sakao S, Tatsumi K. Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities. Int J Cardiol. 2011;147:4–12.
Article
PubMed
Google Scholar
Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol. 1997;28:434–42.
Article
CAS
PubMed
Google Scholar
Mouthon L, Guillevin L, Humbert M. Pulmonary arterial hypertension: an autoimmune disease? Eur Respir J. 2005;26:986–8.
Article
CAS
PubMed
Google Scholar
Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005;115:2811–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Merklinger SL, Jones PL, Martinez EC, Rabinovitch M. Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation. 2005;112:423–31.
Article
CAS
PubMed
Google Scholar
Dahal BK, Cornitescu T, Tretyn A, Pullamsetti SS, Kosanovic D, Dumitrascu R, et al. Role of epidermal growth factor inhibition in experimental pulmonary hypertension. Am J Respir Crit Care Med. 2010;181:158–67.
Article
CAS
PubMed
Google Scholar
Raines EW, Ferri N. Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res. 2005;46:1081–92.
Article
CAS
PubMed
Google Scholar
Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009;19:247–52.
Article
CAS
PubMed
Google Scholar
Mitra AK, Del Core MG, Agrawal DK. Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies. Can J Physiol Pharmacol. 2005;83:701–15.
Article
CAS
PubMed
Google Scholar
Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc. 2006;3:413–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schultz JEJ, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest. 2002;109:787–96.
Article
CAS
PubMed Central
Google Scholar
Peng J, Gurantz D, Tran V, Cowling RT, Greenberg BH. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ Res. 2002;91:1119–26.
Article
CAS
PubMed
Google Scholar
Fairweather D, Frisancho-Kiss S, Yusung S, Barrett M, Gatewood S, Davis S, et al. IFN-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines TGF-β1, IL-1β, and IL-4 in the heart. Am J Pathol. 2004;165:1883–94.
Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002;91:1103–13.
Article
CAS
PubMed
Google Scholar
Eickelberg O, Pansky A, Koehler E, Bihl M, Tamm M, Hildebrand P, et al. Molecular mechanisms of TGF-β antagonism by interferon-γ and cyclosporine a in lung fibroblasts. FASEB J. 2001;15:797–806.
Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-γ inhibits experimental renal fibrosis. Kidney Int. 1999;56:2116–27.
Article
CAS
PubMed
Google Scholar
Ahdieh M, Vandenbos T, Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-γ. Am J Physiol Cell Physiol. 2001;281:C2029–38.
Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99:2691–700.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 1997;99:1313–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart F-X, et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy. 2002;32:237–46.
Article
CAS
PubMed
Google Scholar
Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, et al. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity. 2004;37:131–45.
Article
CAS
PubMed
Google Scholar
Coronado MJ, Brandt JE, Kim E, Bucek A, Bedja D, Abston ED, et al. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am J Physiol Heart Circ Physiol. 2012;302:H1726–H36.
Heath D, Yacoub M. Lung mast cells in plexogenic pulmonary arteriopathy. J Clin Pathol. 1991;44:1003–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyata M, Sakuma F, Ito M, Ohira H, Sato Y, Kasukawa R. Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration. Int Arch Allergy Immunol. 2000;121:246–52.
Article
CAS
PubMed
Google Scholar
Banasová A, Maxová H, Hampl V, Vízek M, Povýsilová V, Novotná J, et al. Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia. Respiration. 2008;76:102–7.
Article
PubMed
Google Scholar
Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun. 2009;33:222–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Graham BB, Kumar R. Schistosomiasis and the pulmonary vasculature (2013 Grover Conference series). Pulm Circ. 2014;4:353–62.
Article
PubMed
PubMed Central
Google Scholar
Sandstrom TS, Ranganath N, Angel JB. Impairment of the type I interferon response by HIV-1: potential targets for HIV eradication. Cytokine Growth Factor Rev. 2017;37:1-16.
Austin ED, Loyd JE. The genetics of pulmonary arterial hypertension. Circ Res. 2014;115:189–202.
Article
CAS
PubMed
PubMed Central
Google Scholar
Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis. 1984;129:194–7.
CAS
PubMed
Google Scholar
Loyd JE, Butler MG, Foroud TM, Conneally PM, Phillips JA, Newman JH. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;152:93–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115:165-75.
Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat. 2015;36:1113–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pesenacker AM, Cook L, Levings MK. The role of FOXP3 in autoimmunity. Curr Opin Immunol. 2016;43:16–23.
Article
CAS
PubMed
Google Scholar
Nasim MT, Ogo T, Chowdhury HM, Zhao L, Chen CN, Rhodes C, et al. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Hum Mol Genet. 2012;21:2548–58.
Article
CAS
PubMed
Google Scholar
Perros F, Cohen-Kaminsky S, Gambaryan N, Girerd B, Raymond N, Klingelschmitt I, et al. Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2013;187:189–96.
Article
CAS
PubMed
Google Scholar
Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Ruiz NP. Sexually dimorphic gene expression in the heart of mice and men. J Mol Med. 2008;86:61–74.
Article
PubMed
Google Scholar
Buskiewicz IA, Huber SA, Fairweather D. Sex hormone receptor expression in the immune system. In: Neigh G, Mitzelfelt M, editors. Sex differences in physiology. London: Elsevier; 2016. p. 45–60.
Chapter
Google Scholar
Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. 2010;9:494–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lahita R. Sex hormones and immune function. In: Legato M, editor. Principles of gender-specific medicine. 2nd ed. London: Elsevier; 2010. p. 615–26.
Chapter
Google Scholar
Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev. 2000;24:627–38.
Article
CAS
PubMed
Google Scholar
Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28:521–74.
Article
CAS
PubMed
Google Scholar
Regitz-Zagrosek V, Becher E, Mahmoodzadeh S, Schubert C. Sex steroid hormones. In: Bader M, editor. Cardiovascular hormone systems: from molecular mechanisms to novel therapeutics. Wiley-Blackwell: Weinheim; 2008. p. 39–64.
Chapter
Google Scholar
Douin-Echinard V, Laffont S, Seillet C, Delpy L, Krust A, Chambon P, et al. Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production. J Immunol. 2008;180:3661–9.
Article
CAS
PubMed
Google Scholar
Carreras E, Turner S, Frank MB, Knowlton N, Osban J, Centola M, et al. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood. 2010;115:238–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kovats S. Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm Behav. 2012;62:254–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seillet C, Rouquie N, Foulon E, Douin-Echinard V, Krust A, Chambon P, et al. Estradiol promotes functional responses in inflammatory and steady-state dendritic cells through differential requirement for activation function-1 of estrogen receptor alpha. J Immunol. 2013;190:5459–70.
Article
CAS
PubMed
Google Scholar
Xie H, Hua C, Sun L, Zhao X, Fan H, Dou H, et al. 17Beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum. 2011;63:2425–35.
Article
CAS
PubMed
Google Scholar
Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, et al. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol. 2007;178:6710–4.
Article
CAS
PubMed
Google Scholar
Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, et al. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immun. 2009;23:649–57.
Article
CAS
PubMed
Google Scholar
Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol. 1997;38:46–54.
Article
CAS
PubMed
Google Scholar
Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res. 2001;89:823–30.
Article
CAS
PubMed
Google Scholar
Chadwick CC, Chippari S, Matelan E, Borges-Marcucci L, Eckert AM, Keith JC Jr, et al. Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc Natl Acad Sci U S A. 2005;102:2543–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Demyanets S, Pfaffenberger S, Kaun C, Rega G, Speidl WS, Kastl SP, et al. The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway. Thromb Haemost. 2006;95:107–16.
Article
CAS
PubMed
Google Scholar
Huang H, He J, Yuan Y, Aoyagi E, Takenaka H, Itagaki T, et al. Opposing effects of estradiol and progesterone on the oxidative stress-induced production of chemokine and proinflammatory cytokines in murine peritoneal macrophages. J Med Investig. 2008;55:133–41.
Article
Google Scholar
Okwan-Duodu D, Umpierrez GE, Brawley OW, Diaz R. Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res. 2013;3:21–33.
CAS
PubMed
PubMed Central
Google Scholar
McCrohon JA, Death AK, Nakhla S, Jessup W, Handelsman DJ, Stanley KK, et al. Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation. 2000;101:224–6.
Article
CAS
PubMed
Google Scholar
Sader MA, McGrath KC, Hill MD, Bradstock KF, Jimenez M, Handelsman DJ, et al. Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clin Endocrinol. 2005;62:56–63.
Article
CAS
Google Scholar
Brechenmacher SA, Bruns CJ, Van den Engel NK, Angele P, Loehe F, Jauch KW, et al. Influence of surgical trauma on the mRNA expression of sex hormone receptors in PBMCs in male and female patients. Langenbeck's Arch Surg. 2008;393:871–6.
Article
CAS
Google Scholar
Yakimchuk K, Jondal M, Okret S. Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol. 2013;375:121–9.
Article
CAS
PubMed
Google Scholar
Aristimuno C, Teijeiro R, Valor L, Alonso B, Tejera-Alhambra M, de Andres C, et al. Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis. Clin Exp Med. 2012;12:247–55.
Article
CAS
PubMed
Google Scholar
Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine. 2008;26:3551–5.
Article
CAS
PubMed
Google Scholar
Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol. 2004;173:2227–30.
Article
CAS
PubMed
Google Scholar
Pulendran B, Tang H, Manicassamy S. Programming dendritic cells to induce TH2 and tolerogenic responses. Nat Immunol. 2010;11:647–55.
Article
CAS
PubMed
Google Scholar
Papenfuss TL, Powell ND, McClain MA, Bedarf A, Singh A, Gienapp IE, et al. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J Immunol. 2011;186:3346–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pennell LM, Galligan CL, Fish EN. Sex affects immunity. J Autoimmun. 2012;38:J282–J91.
Article
CAS
PubMed
Google Scholar
Girón-González JA, Moral FJ, Elvira J, García-Gil D, Guerrero F, Gavilán I, et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol. 2000;143:31–6.
Article
PubMed
Google Scholar
Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab. 2000;85:1648–57.
Article
CAS
PubMed
Google Scholar
Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol. 1998;51:1271–6.
Article
CAS
PubMed
Google Scholar
Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol. 2003;157:923–9.
Article
PubMed
Google Scholar
Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97:1159–68.
Article
CAS
PubMed
PubMed Central
Google Scholar
Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847–53.
Article
CAS
PubMed
Google Scholar
Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22:1041–50.
Article
CAS
PubMed
Google Scholar
Gameiro CM, Romao F, Castelo-Branco C. Menopause and aging: changes in the immune system—a review. Maturitas. 2010;67:316–20.
Article
CAS
PubMed
Google Scholar
White HD, Crassi KM, Givan AL, Stern JE, Gonzalez JL, Memoli VA, et al. CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol. 1997;158:3017–27.
CAS
PubMed
Google Scholar
Shakhar K, Shakhar G, Rosenne E, Ben-Eliyahu S. Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity. Br J Cancer. 2000;83:1630–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bove R. Autoimmune diseases and reproductive aging. Clin Immunol. 2013;149:251–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu HB, Loo KK, Palaszynski K, Ashouri J, Lubahn DB, Voskuhl RR. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J Immunol. 2003;171:6936–40.
Article
CAS
PubMed
Google Scholar
Feldman I, Feldman GM, Mobarak C, Dunkelberg JC, Leslie KK. Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am J Obstet Gynecol. 2007;196:394 e1–11. discussion e11-3
Article
CAS
Google Scholar
Paimela T, Ryhanen T, Mannermaa E, Ojala J, Kalesnykas G, Salminen A, et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol Lett. 2007;110:139–44.
Article
CAS
PubMed
Google Scholar
Farage M, Millwe D, Maibach H. The effects of menopause on autoimmune diseases. In: Farage M, Miller K, Woods N, Maibach H, editors. Skin, mucosa and menopause: management of clinical issues. Heidelberg: Springer; 2015. p. 299–318.
Google Scholar
Vitale C, Mendelsohn M, Rosano G. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol. 2009;6:532–42.
Article
CAS
PubMed
Google Scholar
Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest. 2001;107:333–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152:4489–95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cavasin MA, Tao Z-Y, Yu A-L, Yang X-P. Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function. Am J Physiol Heart Circ Physiol. 2006;290:H2043–50.
Article
CAS
PubMed
Google Scholar
Resta TC, Kanagy NL, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol. 2001;280:L88–97.
Article
CAS
PubMed
Google Scholar
Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1013–32.
Article
CAS
PubMed
Google Scholar
Dai Z, Zhao YY. Discovery of a murine model of clinical PAH: mission impossible? Trends Cardiovasc Med. 2017;27:229–36.
Article
CAS
PubMed
Google Scholar
Sztuka K, Jasinska-Stroschein M. Animal models of pulmonary arterial hypertension: a systematic review and meta-analysis of data from 6126 animals. Pharmacol Res. 2017;125:201–14.
Article
PubMed
Google Scholar
Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Phys. 1981;240:H62–72.
CAS
Google Scholar
Lahm T, Albrecht M, Fisher AJ, Selej M, Patel NG, Brown JA, et al. 17Beta-estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am J Respir Crit Care Med. 2012;185:965–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tofovic SP, Salah EM, Mady HH, Jackson EK, Melhem MF. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol. 2005;46:430–7.
Article
CAS
PubMed
Google Scholar
Austin ED, Hamid R, Hemnes AR, Loyd JE, Blackwell T, Yu C, et al. BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ. 2012;3:6.
Article
CAS
PubMed
PubMed Central
Google Scholar
West J, Cogan J, Geraci M, Robinson L, Newman J, Phillips JA, et al. Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genet. 2008;1:45.
Google Scholar
Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R, et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci. 2002;966:238–46.
Article
PubMed
Google Scholar
Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol. 2006;35:468–71.
Article
CAS
PubMed
Google Scholar
Generini S, Seibold JR, Matucci-Cerinic M. Estrogens and neuropeptides in Raynaud's phenomenon. Rheum Dis Clin N Am. 2005;31:177–86.
Article
Google Scholar
Tamosiuniene R, Manouvakhova O, Mesange P, Saito T, Qian J, Sanyal M, et al. A dominant role for regulatory T cells in protecting females against pulmonary hypertension. Circ Res. 2018. [Epub ahead of print].
McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of pulmonary arterial hypertension. J Am Coll Cardiol. 2015;65:1976–97.
Article
PubMed
Google Scholar